
The present invention relates to acylated indanyl amines according to the general formula (I) ##STR00001## wherein R.sup.1 R.sup.4 have the meanings given in the description, A is CH.sub.2, CHOH or CH--(C.sub.1 C.sub.3-alkyl), B is CH.sub.2 or CH--(C.sub.1 C.sub.3-alkyl), and R.sup.5 is an aryl or heteroaryl group, possibly substituted by the substituents listed in the description. These compounds are useful in the upregulation of endothelial nitric oxide synthase (eNOS), and may therefore be us...










